The Classification of Gasoline & Gasoline Fumes as a Carcinogen: Considerations for Corporate Executives & Attorneys
What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2023
PFAS in Focus: Forever-Engineering With Trent Stober, HDR - Reflections on Water Podcast
PFAS in Focus: Wastewater Utility Perspectives From Jay Hoskins, Metropolitan St. Louis Sewer District - Reflections on Water Podcast
[Podcast] Catching Up on Canadian Environmental Regulation
PFAS: Increasing Regulations and Managing Legal Liability
EPA Plan Changes PFAS Outlook For Companies, Regulators
2BInformed: The EPA’s Impact on Supply Chains and Climate Change, and Defining “Unreasonable Risk”
2BInformed: Understanding the EPA’s New PFAS Strategic Roadmap and Upcoming PBT Regulations
2BInformed: Overview of PFAS and Related EPA Regulations; EPA’s New Chemical Program Under Amended TSCA
2BInformed: How TSCA Amendments Impact Industries and Managing the EPA’s Risk Evaluations
2BInformed: The Future of Fluoride in Drinking Water, the New TSCA Fees Rule, and the Drinking Water Contaminant Candidate List 5
Starting 2BInformed: The Inaugural Episode of the Podcast Series, ‘2BInformed,’ with Baptist and Bertrand
The Great Green North: A Discussion on Canada’s Environmental Regulations
Wiley Biotech Briefings – An Advanced Course for the Regulatory Professional: TSCA and Industrial Biotechnology
Forever Chemicals: What They are and What is being Done to Minimize Their Impact
One-on-One with David Fotouhi, Acting General Counsel at the EPA
What are PFAS and Why Should We Care?
On August 20, 2025, the European Chemicals Agency (“ECHA”) published the updated REACH PFAS Restriction Proposal....more
PFAS are a chemically diverse family of over 10,000 synthetic fluorinated compounds, all containing at least one carbon-fluorine (C–F) bond. This makes them highly persistent and earns them the nickname "forever chemicals."...more
The U.S. Food and Drug Administration (FDA) is overhauling its approach to post-market oversight of food chemicals, marked by the proposed rollout of a new Post-Market Assessment Prioritization Tool. The FDA first announced...more